Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alimera Sciences Inc (ALIM)

Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alimera Sciences: Q2 Earnings Snapshot

Alimera Sciences: Q2 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q2 Earnings Snapshot

Alimera Sciences: Q2 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 5.54 (-0.18%)
Alimera Sciences to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be...

ALIM : 5.54 (-0.18%)
Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Portugal

Reimbursement granted with no restrictions to the labelAlimera to begin selling later in Q3 ATLANTA, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences,...

ALIM : 5.54 (-0.18%)

Barchart Exclusives

Dividend Aristocrats: The Best of the Best for Stable Income
Dividend Aristocrats' ability to increase their dividends indicates strong earnings and a solid business foundation, which lowers investment risk. Moreover, their consistent earnings growth often enables them to outperform broader market indices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar